JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M502298200 on January 24, 2006

J. Biol. Chem., Vol. 281, Issue 12, 8082-8089, March 24, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/12/8082    most recent
M502298200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goumon, Y.
Right arrow Articles by Metz-Boutigue, M.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goumon, Y.
Right arrow Articles by Metz-Boutigue, M.-H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Identification of Morphine-6-glucuronide in Chromaffin Cell Secretory Granules*

Yannick Goumon{ddagger}1, Arnaud Muller{ddagger}, Elise Glattard{ddagger}, Céline Marban{ddagger}, Claire Gasnier{ddagger}, Jean-Marc Strub§, Sylvette Chasserot-Golaz, Olivier Rohr{ddagger}, George B. Stefano||, Ingeborg D. Welters**, Alain Van Dorsselaer§, Françoise Schoentgen{ddagger}{ddagger}, Dominique Aunis{ddagger}, and Marie-Hélène Metz-Boutigue{ddagger}

From the {ddagger}Physiopathologie du Système Nerveux, INSERM U575, 67084 Strasbourg, France, the §Laboratoire de Spectrométrie de Masse BioOrganique, CNRS UMR 7168/LC2, 67087 Strasbourg, France, the Laboratoire de Neurotransmission et Sécrétion Neuroendocrine, CNRS UPR 2356, 67084 Strasbourg, France, the ||Neuroscience Research Institute, State University of New York, Old Westbury, New York, New York 11568, the **Department of Anesthesiology, Intensive Care, and Pain Medicine, Justus-Liebig-Universität, 35385 Giessen, Germany, and the {ddagger}{ddagger}Centre de Biophysique Moléculaire, CNRS UPR 4301, 45071 Orléans, France

We report for the first time that morphine-6-glucuronide, a highly analgesic morphine-derived molecule, is present in adrenal chromaffin granules and secreted from chromaffin cells upon stimulation. We also demonstrate that phosphatidylethanolamine-binding protein (alternatively named Raf-1 kinase inhibitor protein or RKIP) acts as an endogenous morphine-6-glucuronide-binding protein. An UDP-glucuronosyltransferase 2B-like enzyme, described to transform morphine into morphine-6-glucuronide, has been immunodetected in the chromaffin granule matrix, and morphine-6-glucuronide de novo synthesis has been characterized, demonstrating the possible involvement of intragranular UDP-glucuronosyltransferase 2B-like enzyme in morphine-6-glucuronide metabolism. Once secreted into the circulation, morphine-6-glucuronide may mediate several systemic actions (e.g. on immune cells) based on its affinity for µ-opioid receptors. These activities could be facilitated by phosphatidylethanolamine-binding protein (PEBP), acting as a molecular shield and preventing morphine-6-glucuronide from rapid clearance. Taken together, our data represent an important observation on the role of morphine-6-glucuronide as a new endocrine factor.


Received for publication, March 1, 2005 , and in revised form, January 5, 2006.

* This work was supported by INSERM, Université Louis Pasteur Strasbourg, Ph.D. grants from the Région Alsace (to C. M.) and the French Ministère Délégué à la Recherche et à l'Enseignement Supérieur (to E. G. and A. M.), the Fondation pour la Recherche Médicale (to M.-H. M.-B.), the Ligue Contre le Cancer (to D. A.), and Hôpital Universitaire de Strasbourg Programme Hospitalier de Recherche Clinique 3150 (to M.-H. M.-B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: INSERM U575, 5, rue Blaise Pascal, 67084 Strasbourg, France. Tel.: 33-3-8845-6724; Fax: 33-3-8860-0806; E-mail: goumon{at}neurochem.u-strasbg.fr.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.